Clinical relevance of reduced bioavailability of rifampicin.
Article
in English
| IMSEAR
| ID: sea-89296
ABSTRACT
Bioavailability (BA) of rifampicin (RMP) is a critical factor in successful treatment of tuberculosis. The BA of RMP can be reduced by pharmaceutical factors, patient factors and drug interactions. Failure of treatment and development of drug resistance are potential consequences of reduction in BA and it is necessary to understand and control the factors influencing BA of RMP.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Rifampin
/
Tuberculosis
/
Humans
/
Biological Availability
/
Drug Interactions
/
Antitubercular Agents
Language:
English
Year:
1998
Type:
Article
Similar
MEDLINE
...
LILACS
LIS